Lineage, Inc. Common Stock (LINE)vsTerreno Realty Corporation (TRNO)
LINE
Lineage, Inc. Common Stock
$42.36
+4.23%
REAL ESTATE · Cap: $10.62B
TRNO
Terreno Realty Corporation
$68.76
+0.90%
REAL ESTATE · Cap: $7.57B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 993% more annual revenue ($5.36B vs $490.40M). TRNO leads profitability with a 86.5% profit margin vs -2.7%. TRNO earns a higher WallStSmart Score of 68/100 (B-).
LINE
Hold36
out of 100
Grade: F
TRNO
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+69.0%
Fair Value
$211.33
Current Price
$68.76
$142.57 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Keeps 87 of every $100 in revenue as profit
Strong operational efficiency at 40.7%
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 40.2% YoY
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : TRNO
The strongest argument for TRNO centers on Profit Margin, Operating Margin, Debt/Equity. Profitability is solid with margins at 86.5% and operating margin at 40.7%. Revenue growth of 12.7% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : TRNO
The primary concerns for TRNO are PEG Ratio.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while TRNO is a mature play — different risk/reward profiles.
TRNO carries more volatility with a beta of 1.06 — expect wider price swings.
TRNO is growing revenue faster at 12.7% — sustainability is the question.
TRNO generates stronger free cash flow (37M), providing more financial flexibility.
Bottom Line
TRNO scores higher overall (68/100 vs 36/100), backed by strong 86.5% margins and 12.7% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Terreno Realty Corporation
REAL ESTATE · REIT - INDUSTRIAL · USA
Terreno Realty Corporation and together with its subsidiaries, the?
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?